Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Relapse
Apr 01, 2020
New Telehealth Service Helps Reduce Relapse Risk for Those in Recovery; Hiring Increased by 50% to Meet Demand
Mar 09, 2020
DrFirst and GoHipo Partner to Use Telehealth to Fight High Relapse Rates After Substance Abuse Treatment by Addressing Major Gaps in Post-Inpatient Rehabilitation
Feb 27, 2020
Mallinckrodt to Present New Data from two Studies on Acthar® Gel (Repository Corticotropin Injection) Therapy in Multiple Sclerosis (MS) Relapse at Fifth Annual ACTRIMS Forum 2020
Nov 07, 2019
Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) for Resolution of Multiple Sclerosis Relapse in a U.S. Health Plan Population
Sep 13, 2019
Mallinckrodt Analysis Suggests Acthar® Gel (Repository Corticotropin Injection) May be a Cost-Effective Option Compared to Other Late-Line, Adult Treatments for Multiple Sclerosis Relapse
Mar 28, 2019
Amygdala Neurosciences Announces Dosing the First Patients in the $12.4 Million NIH HEAL Initiative Funded SEARCH Program of Clinical Studies with ANS-6637
Feb 26, 2019
The Issue of Relapse and Addiction Tackled by Recovery Centers of America in New Treatment Program at Devon, PA Campus
Jan 31, 2019
CHESS Health, Australian Justice Center Partner to Provide eRecovery Technology to Substance Use Disorder Clients
Jan 17, 2019
American Addiction Centers Releases Five Tips to Beat the Winter Blues & Stay Sober
Dec 13, 2018
Drug and Alcohol Relapse Rates Spike 150% during the Holidays
Nov 16, 2018
American Addiction Centers Releases 10 Tips to Stay Sober During the Holidays
Sep 19, 2018
Amygdala Neurosciences Announces the $12.4 Million HEAL Initiative Sponsored SEARCH (Safety and Efficacy of ANS-6637 to Reduce Drug Craving and Harm in People with Opioid Use Disorder) Program of Phase 2 Clinical Studies
Sep 12, 2018
Amygdala Neurosciences and NIAAA will Conduct a Phase 2 Clinical study of ANS-6637 for the Treatment of Alcohol Use Disorder
Aug 28, 2018
Brain Research Foundation (BRF) awards two grants to help identify new treatments to reduce opioid relapse
Oct 27, 2017
Patient Survey Studies Find Multiple Sclerosis Relapse is Underreported; Approximately Half of Patients Do Not Always Engage with Healthcare Practitioners During Relapse
Oct 26, 2017
Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)
Aug 01, 2017
Amygdala Neurosciences Initiates Phase 1b Clinical Study of ANS-6637, the First-In-Class Selective ALDH2 Inhibitor in Development as a Treatment for Substance Use Disorder
Latest News
Mar 28, 2024
Slip Robotics Wins Best New Innovation in the Supply Chain at MODEX 2024
Mar 28, 2024
South Africa Motor Vehicle Industry Report 2023: Muted Domestic Sales and Export Slowdown Propose Challenges...
Mar 28, 2024
Gresham Worldwide, Inc. Announces New Head of Israeli Defense Subsidiary
Mar 28, 2024
Solace Capital Partners Provides Growth Capital to Siprocal
Mar 28, 2024
Cognyte to Announce Fourth Quarter and Full Year FY2024 Financial Results on April 9, 2024
Mar 28, 2024
Iveda Finds 84% of Americans Are Concerned About Violence in The Country; Many Believe AI Could Help
Mar 28, 2024
Voltera Welcomes Marie Robinson to Its Board of Directors
Mar 28, 2024
Former Army Maj. Gen. John B. Richardson IV Joins USAA To Lead Military Affairs
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events